High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma – Results of a comprehensive meta-analysis-Reference-Cited by-同舟云学术

High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma – Results of a comprehensive meta-analysis

Published:2007-06 Issue:4 Volume:33 Page:338-346
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Greb Alexander,Bohlius Julia,Trelle Sven,Schiefer Daniel,De Souza Carmino A.,Gisselbrecht Christian,Intragumtornchai Tanin,Kaiser Ulrich,Kluin-Nelemans Hanneke C.,Martelli Maurizio,Milpied Noel Jean,Santini Gino,Verdonck Leo F.,Vitolo Umberto,Schwarzer Guido,Engert Andreas

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference47 articles.

1. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002

2. Introduction of combined CHOP plus Rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia;Sehn;J Clin Oncol,2005

3. Chemotherapy of malignant lymphoma with adriamycin;Gottlieb;Cancer Res,1973

4. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma;McKelvey;Cancer,1976

5. A review of recruitment criteria, patient characteristics and results of CHOP chemotherapy in prospective randomized phase III clinical trials for aggressive non-Hodgkin’s lymphoma;van Agthoven;Hematol J,2003

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis;Blood Advances;2020-05-07

2. Upfront autologous stem cell transplantation for untreated diffuse large B cell lymphoma patients in rituximab era: a systematic review and meta-analysis;Annals of Hematology;2020-04-13

3. Upfront autologous hematopoietic stem cell transplantation consolidation for patients with aggressive B‐cell lymphomas in first remission in the rituximab era: A systematic review and meta‐analysis;Cancer;2019-08-23

4. Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation;Clinical Lymphoma Myeloma and Leukemia;2019-06

5. Prognostic significance of retention index of bone marrow on dual-phase 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with diffuse large B-cell lymphoma;Medicine;2018-01